These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 30416310)

  • 1. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF; Bernardazzi C; Castro F; de Souza HSP
    World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: new therapies from antisense oligonucleotides.
    Marafini I; Monteleone G
    Ann Med; 2018 Aug; 50(5):361-370. PubMed ID: 29911450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders.
    Loktionov A
    World J Gastroenterol; 2019 Jul; 25(27):3503-3526. PubMed ID: 31367153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.
    Boyapati RK; Rossi AG; Satsangi J; Ho GT
    Mucosal Immunol; 2016 May; 9(3):567-82. PubMed ID: 26931062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.
    Ryan FJ; Ahern AM; Fitzgerald RS; Laserna-Mendieta EJ; Power EM; Clooney AG; O'Donoghue KW; McMurdie PJ; Iwai S; Crits-Christoph A; Sheehan D; Moran C; Flemer B; Zomer AL; Fanning A; O'Callaghan J; Walton J; Temko A; Stack W; Jackson L; Joyce SA; Melgar S; DeSantis TZ; Bell JT; Shanahan F; Claesson MJ
    Nat Commun; 2020 Mar; 11(1):1512. PubMed ID: 32251296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 13. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
    Bates J; Diehl L
    J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed.
    Subramanian A; Jahabardeen A; Thamaraikani T; Vellapandian C
    World J Gastroenterol; 2024 Jul; 30(27):3356-3360. PubMed ID: 39086745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced CD27
    Pararasa C; Zhang N; Tull TJ; Chong MHA; Siu JHY; Guesdon W; Chavele KM; Sanderson JD; Langmead L; Kok K; Spencer J; Vossenkamper A
    Front Immunol; 2019; 10():361. PubMed ID: 30891036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting immune cell circuits and trafficking in inflammatory bowel disease.
    Neurath MF
    Nat Immunol; 2019 Aug; 20(8):970-979. PubMed ID: 31235952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome.
    Ghaly S; Hart PH; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1039-1048. PubMed ID: 31657973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.